http://www.ambergen.com/wp-content/uploads/logo-retina.png 0 0 Kenneth Rothschild http://www.ambergen.com/wp-content/uploads/logo-retina.png Kenneth Rothschild2012-09-27 13:44:382016-11-10 12:44:45AmberGen awarded Phase I SBIR grant for the application of photocleavable bead technology to glycomics
Get in Touch
313 Pleasant St.
Watertown, MA 02472
- Dr. Gargey Yagnik joins AmberGen as Program Coordinator for Mass Spectrometry. In his previous position as a postdoctoral researcher at Sanofi Genzyme he developed new methods for MALDI-MSI tissue imaging. He received his Ph.D. from Iowa State University in analytical chemistry. January 2017
- AmberGen awarded two US Patents (9,334,530 and 9,523,680) providing broad coverage for its Bead-AMS™ technology December 2016